MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pathology

• Publication date

  2009-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/path.2586PMID 19593777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.

  2008cited by this paper
• MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

  2008influential reference
• MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death

  2008cited by this paper
• MicroRNA-155 Is Regulated by TGF β / Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

  2008cited by this paper
• Rapid Changes in MicroRNA-146a Expression Negatively Regulate the IL-1β-Induced Inflammatory Response in Human Lung Alveolar Epithelial Cells1

  2008cited by this paper
• MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors

  2008cited by this paper
• Benign Metastasizing Leiomyoma of the Lung: Clinicopathologic, Immunohistochemical, and Micro-RNA Analyses

  2008cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2008influential reference
• Identification of metastasis‐related microRNAs in hepatocellular carcinoma

  2008influential reference
• Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

  2008cited by this paper
• Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling

  2008cited by this paper
• MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.

  2008cited by this paper
• Endogenous human microRNAs that suppress breast cancer metastasis

  2008cited by this paper
• MicroRNAs, the immune system and rheumatic disease

  2008cited by this paper
• MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

  2008cited by this paper
• MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008influential reference
• MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

  2008cited by this paper
• Breast cancer metastasis: a microRNA story

  2008cited by this paper
• MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

  2008cited by this paper
• The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

  2008cited by this paper
• Re-evaluation of mammary stem cell biology based on in vivo transplantation

  2008cited by this paper
• A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

  2008cited by this paper
• The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

  2008cited by this paper
• Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells*

  2008cited by this paper
• A microRNA DNA methylation signature for human cancer metastasis

  2008cited by this paper
• The miR-200 Family Inhibits Epithelial-Mesenchymal Transition and Cancer Cell Migration by Direct Targeting of E-cadherin Transcriptional Repressors ZEB1 and ZEB2*

  2008cited by this paper
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

  2007cited by this paper
• MicroRNA-155 is induced during the macrophage inflammatory response

  2007cited by this paper
• Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids

  2007cited by this paper
• Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

  2007cited by this paper
• MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype

  2007cited by this paper
• Differential expression of microRNAs with progression of gestation and inflammation in the human chorioamniotic membranes.

  2007cited by this paper
• MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype

  2007cited by this paper
• A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance

  2007cited by this paper
• Loss of programmed cell death 4 expression marks adenoma‐carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer

  2007influential reference
• Modulation of miR-155 and miR-125b Levels following Lipopolysaccharide/TNF-α Stimulation and Their Possible Roles in Regulating the Response to Endotoxin Shock1

  2007cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• miRNAs, cancer, and stem cell division.

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• Aberrant expression of HOX genes in human invasive breast carcinoma.

  2005cited by this paper
• Extensive modulation of a set of microRNAs in primary glioblastoma.

  2005cited by this paper
• Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model.

  2005cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

  2004cited by this paper
• An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues.

  2004cited by this paper
• Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1).

  2004cited by this paper
• Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21Waf1/Cip1

  2004cited by this paper
• Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis

  2003cited by this paper
• Sustained expression of homeobox D10 inhibits angiogenesis.

  2002cited by this paper
• Molecular mechanisms of resistance to antifolates, a review.

  1995cited by this paper

• Lipid metabolic alterations in cancer: common pathophysiology with cardiovascular disease.

  2026cites this paper
• The promise of liquid biopsies in prostate cancer: a potential point-of-care modality for precision oncology

  2025cites this paper
• Identification of novel microRNAs: Biomarkers for pathogenesis of hepatocellular carcinoma in mice model

  2025cites this paper
• miR-10b as a Clinical Marker and a Therapeutic Target for Metastatic Breast Cancer

  2025cites this paper
• Diagnostic value of microRNA-129-5p and TSH combination for papillary thyroid cancer with cervical lymph node metastasis

  2025cites this paper
• Myofibrillar protein accumulation but reduced protein synthesis in PDCD4-depleted myotubes

  2025cites this paper
• Construction and Identification of Inflammation-Related TF–mRNA–miRNA Coexpression Network and Immune Infiltration in Parkinson's Disease

  2025cites this paper
• Profiles of differential expression of miRNAs in the late stage of red blood cell preservation and their potential roles.

  2024cites this paper
• Inhibition of miR-10b treats metastatic breast cancer by targeting stem cell-like properties

  2024cites this paper
• Differentially deregulated microRNAs contribute to ultraviolet radiation-induced photocarcinogenesis through immunomodulation: An-analysis of microRNAs expression profiling

  2023cites this paper
• MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer

  2023cites this paper
• Homeobox Gene Expression Dysregulation as Potential Diagnostic and Prognostic Biomarkers in Bladder Cancer

  2023cites this paper
• From molecular basis to clinical insights: a challenging future for the vitamin D endocrine system in colorectal cancer

  2023cites this paper
• ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!

  2023cites this paper
• Emerging role of miRNA in prostate cancer: A future era of diagnostic and therapeutics.

  2023cites this paper
• Case report: MicroRNA-10b as a therapeutic target in feline metastatic mammary carcinoma and its implications for human clinical trials

  2022cites this paper
• microRNA-Based Biomarkers in Lung Cancer: Recent Advances and potential Applications.

  2022cites this paper
• miR-30 inhibits the progression of osteosarcoma by targeting MTA1

  2022cites this paper
• The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract

  2022cites this paper
• A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer

  2022cites this paper
• miR‐450a exerts oncosuppressive effects in breast carcinoma by targeting CREB1

  2022cites this paper
• miRNAs Contained in Extracellular Vesicles Cargo Contribute to the Progression of Idiopathic Pulmonary Fibrosis: An In Vitro Aproach

  2022cites this paper
• Analysis of the p53/microRNA Network in Cancer.

  2022cites this paper
• CircEPSTI1 Promotes the Proliferation of HER2-Positive Breast Cancer Cells via circEPSTI1/miR-145/ERBB3 Axis

  2022cites this paper
• The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma

  2022cites this paper
• In silico analysis revealed the potential circRNA-miRNA-mRNA regulative network of non-small cell lung cancer (NSCLC)

  2022cites this paper
• Regulation of antitumor miR-205 targets oncogenes: Direct regulation of lymphoid specific helicase and its clinical significance.

  2022cites this paper
• Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review

  2022cites this paper
• Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles

  2022cites this paper
• A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer

  2022cites this paper
• Circulating miRNAs in Breast Cancer Diagnosis and Prognosis

  2022cites this paper
• miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway

  2021cites this paper
• Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis

  2021cites this paper
• Easy-to-make-and-use gold nanotrench arrays for surface-enhanced Raman scattering

  2021cites this paper
• The clinical significance of circulating miR-21, miR-142, miR-143, and miR-146a in patients with prostate cancer

  2021cites this paper
• Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis

  2021cites this paper
• Inhibition of the cell migration, invasion and chemoresistance of colorectal cancer cells through targeting KLF3 by miR-365a-3p

  2021cites this paper
• Enzyme-free amplified detection of cellular microRNA by light-harvesting fluorescent nanoparticle probes.

  2021cites this paper
• Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities

  2021cites this paper
• Downregulation of miR-143/145 Cluster in Breast Carcinoma Specimens: Putative Role of DNA Oncoviruses

  2021cites this paper
• Detection of Circulating Serum microRNA/Protein Complexes in ASD Using Functionalized Chips for an Atomic Force Microscope

  2021cites this paper
• CBFβ promotes colorectal cancer progression through transcriptionally activating OPN, FAM129A, and UPP1 in a RUNX2-dependent manner

  2021cites this paper
• The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders

  2021cites this paper
• Modulation of noncoding RNAs (ncRNAs) and their potential role as therapeutics

  2021cites this paper
• miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis

  2020cites this paper
• A microRNA Signature of Metastatic Colorectal Cancer

  2020cites this paper
• Synthesis of 2′‐Deoxyuridine Modified with a 3,5‐Difluoro‐4‐Methoxybenzylidene Imidazolinone Derivative for Incorporation into Oligonucleotide Probes for Detection of HER2 Breast Cancer Marker

  2020cites this paper
• Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers

  2020cites this paper
• Towards a consensus microRNA signature of primary and metastatic colorectal cancer

  2020cites this paper
• Fibroblast-derived exosomal microRNA-369 potentiates migration and invasion of lung squamous cell carcinoma cells via NF1-mediated MAPK signaling pathway

  2020cites this paper
• EMT in breast cancer metastasis: an interplay of microRNAs, signaling pathways and circulating tumor cells.

  2020cites this paper
• miR-205 in Breast Cancer: State of the Art

  2020cites this paper
• Expression and diagnostic value of miR-34c and miR-141 in serum of patients with colon cancer

  2020cites this paper
• Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies

  2020cites this paper
• A three serum miRNA panel as diagnostic biomarkers of radiotherapy-related metastasis in non-small cell lung cancer

  2020cites this paper
• miR-532-3p Inhibits Proliferation and Promotes Apoptosis of Lymphoma Cells by Targeting β-Catenin

  2020cites this paper
• Inhibition of MiR-10b Restrains the Migration and Epithelial-Mesenchymal Transition of Lung Cells by Targeting LATS2 via TAZ Pathway

  2020cites this paper
• Hsa-miR-155-5p Up-Regulation in Breast Cancer and Its Relevance for Treatment With Poly[ADP-Ribose] Polymerase 1 (PARP-1) Inhibitors

  2020cites this paper
• MicroRNAs in breast cancer: New maestros defining the melody.

  2020cites this paper
• Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme

  2020cites this paper
• Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer.

  2019cites this paper
• Molecular beacon immobilized on graphene oxide for enzyme-free signal amplification in electrochemiluminescent determination of microRNA

  2019cites this paper
• Circulating MiR-10b, MiR-1 and MiR-30a Expression Profiles in Lung Cancer: Possible Correlation with Clinico-pathologic Characteristics and Lung Cancer Detection.

  2019cites this paper
• Gastric Cancer MicroRNAs Meta-signature.

  2019cites this paper
• Molecular expression profiles of selected microRNAs in colorectal adenocarcinoma in patients from south-eastern part of Romania

  2019cites this paper
• Role of androgen and microRNA in triple-negative breast cancer

  2019cites this paper
• The mechanisms and clinical significance of PDCD4 in colorectal cancer.

  2019cites this paper
• Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level

  2019cites this paper
• miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

  2019cites this paper
• miR‐30e‐5p suppresses cell proliferation and migration in bladder cancer through regulating metadherin

  2019cites this paper
• Overexpression of hsa-miR-186 induces chromosomal instability in arsenic-exposed human keratinocytes.

  2019cites this paper
• Brain metastasis-related microRNAs in patients with advanced breast cancer

  2019cites this paper
• Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets

  2019cites this paper
• MicroRNA profiling of pancreatic ductal adenocarcinoma (PDAC) reveals signature expression related to lymph node metastasis

  2019cites this paper
• MicroRNA-10b controls the metastasis and proliferation of colorectal cancer cells by regulating Krüppel-like factor 4

  2019cites this paper
• Factors influencing diagnosis and outcome in HER2 receptor positive breast cancer

  2019cites this paper
• TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility

  2019cites this paper
• Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent.

  2019cites this paper
• Human Papillomavirus Infections, Cervical Cancer and MicroRNAs: An Overview and Implications for Public Health

  2019cites this paper
• MiR-181c affects estrogen-dependent endometrial carcinoma cell growth by targeting PTEN.

  2019cites this paper
• microRNA-141 as a diagnostic and prognostic biomarker for prostate cancer in Egyptian population: Pilot study

  2018cites this paper
• The Nefarious Nexus of Noncoding RNAs in Cancer

  2018cites this paper
• miR-30a inhibits epithelial-mesenchymal transition and metastasis in triple-negative breast cancer by targeting ROR1

  2018cites this paper
• [Chloroquine induces apoptosis of human hepatocellular carcinoma cells in vitro by miR-26b-mediated regulation of Mcl-1].

  2018cites this paper
• Confirmation of a metastasis-specific microRNA signature in primary colon cancer

  2018cites this paper
• Development of Cost-effective Tetra-primer Amplification Refractory Mutation System (T-ARMS) PCR for the Detection of miR-146a gene rs2910164 C/G Polymorphism in Breast Cancer

  2018cites this paper
• Expression of MicroRNA-221 in Korean Patients with Multiple Myeloma

  2018cites this paper
• Key microRNAs in the biology of breast cancer; emerging evidence in the last decade

  2018cites this paper
• MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions.

  2018cites this paper
• The Unknown microRNA Expression of Male Breast Cancer. Similarities and Differences with Female Ductal Carcinoma. Their Role as Tumor Biomarker

  2018cites this paper
• The fundamental role of miR-10b in metastatic cancer.

  2018cites this paper
• Methylation deregulation of miRNA promoters identifies miR124-2 as a survival biomarker in Breast Cancer in very young women

  2018cites this paper
• MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma

  2018cites this paper
• Identification of microRNA signature in the progression of gestational trophoblastic disease

  2018cites this paper
• Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs

  2018cites this paper
• Potent and selective effect of the mir-10b inhibitor MN-anti-mir10b in human cancer cells of diverse primary disease origin

  2018cites this paper
• Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.

  2018cites this paper
• Recurrence prediction using microRNA expression in hormone receptor positive breast cancer during tamoxifen treatment

  2018cites this paper
• MicroRNA-30 mediates cell invasion and metastasis in breast cancer.

  2018cites this paper
• miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer.

  2018cites this paper